Pharmacologic and Pharmacokinetic Profile of Mibefradil, a T- and L-type Calcium Channel Antagonist
Open Access
- 1 August 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (4) , 4C-11C
- https://doi.org/10.1016/s0002-9149(97)00564-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Calcium channel diversity in the cardiovascular systemJournal of the American College of Cardiology, 1996
- The binding interactions of Ro 40-5967 at the L-type Ca2+ channel in cardiac tissueEuropean Journal of Pharmacology, 1995
- Selective inhibition of T-type Ca2+ channels by Ro 40-5967.Circulation Research, 1994
- T-type Ca2+ current is expressed in hypertrophied adult feline left ventricular myocytes.Circulation Research, 1993
- Calcium AntagonistsAmerican Journal of Hypertension, 1991
- Calcium Channels, Stores, and OscillationsAnnual Review of Cell Biology, 1990
- In Vitro Pharmacologic Profile of Ro 40-5967, a Novel Ca2+ Channel Blocker with Potent Vasodilator but Weak Inotropic ActionJournal of Cardiovascular Pharmacology, 1989
- Classes of Calcium Channels in Vertebrate CellsAnnual Review of Physiology, 1989
- Pharmacokinetics of Calcium Antagonists Under DevelopmentClinical Pharmacokinetics, 1988
- Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino‐atrial node cells.The Journal of Physiology, 1988